Results 261 to 270 of about 7,716,482 (438)

Reproductive technologies — a long-term cost [PDF]

, 2001
Tanita Casci
openalex   +1 more source

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

Conception and Concern: A Review of Breast Cancer Risk in Assisted Reproductive Technology. [PDF]

Int J Biol Sci
Guo Z, Zhu Z, Lin X, Zhang KM, Wu Q, Wang S, Luo M, Lin X, Wang L, Zhou J.   +9 more
europepmc   +1 more source

Electroejaculation and assisted reproductive technologies in the treatment of anejaculatory infertility [PDF]

, 2001
Dana A. Ohl, Lynda Wolf, Alan C. Menge, Gregory M. Christman, William W. Hurd, Rudi Ansbacher, Yolanda R. Smith, John F. Randolph   +7 more
openalex   +1 more source

TRPM8 levels determine tumor vulnerability to channel agonists

Molecular Oncology, EarlyView.
TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo, Francesco Giuseppe Carbone, Kristi Buzo, Nicole Annesi, Sacha Genovesi, Annalisa Lorenzato, Karen Widmann, Michela Libergoli, Elisa Marmocchi, Giovanni Bertalot, Alberto Brolese, Mauro Giulio Papotti, Luca Molinaro, Orazio Caffo, Mattia Barbareschi, Alberto Bardelli, Alessandro Romanel, Sabrina Arena, Andrea Lunardi   +18 more
wiley   +1 more source

Establishing a predictive model for ectopic pregnancy risk following assisted reproductive technology. [PDF]

BMC Pregnancy Childbirth
Li J, Dai T, Liu Y, Li Y, Chen T, Chen X, Jin L.   +6 more
europepmc   +1 more source

Comparison of implantation and pregnancy rates in African American and white women in an assisted reproductive technology practice [PDF]

, 2001
John E. Nichols, H. Lee Higdon, Martin M. Crane, William R. Boone   +3 more
openalex   +1 more source

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

Molecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine, Sterenn Guillemot, Louis‐Bastien Weiswald, Romane Florent, Edwige Abeilard, Florence Giffard, Emilie Brotin, Mélanie Briand, Enora Dolivet, Laurent Poulain, Marie Villedieu   +10 more
wiley   +1 more source

Ethical Imperatives in the Integration of Artificial Intelligence in Assisted Reproductive Technology. [PDF]

J Hum Reprod Sci
Nair N, Badge AK, Mishra V, Bankar NJ.
europepmc   +1 more source

The future of international registries for assisted reproductive technologies [PDF]

, 2001
Jean Cohen
openalex   +1 more source